StockClub

ALGS

ALGSAligos Therapeutics, Inc.$ --
Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc.

ALGS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2025 Q4Updated: 12/31/2025

Revenue

attach_money
0M USD
-

Operating Income

trending_up
-22M USD
-

Net Income

verified
-20M USD
-

EPS

paid
-1.91$
-

Revenue

$169,000

BEAT
$500,000
$311,000
Q1
$433,333
$965,000
Q2
$500,000
$741,000
Q3
$440,000
$169,000
Q4
$1.9M
$2.2M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Net Income

$-19.9M

BEAT
$-30.9M
$43.1M
Q1
$-24.5M
$-15.9M
Q2
$-19.7M
$-31.5M
Q3
$-25.8M
$-19.9M
Q4
$-101M
$-24.2M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Surprise History

ActualEstimate
FY2025MISS
$2.2M

Future Forecast